4//SEC Filing
Pieton Thierry 4
Accession 0001613103-25-000114
CIK 0001613103other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:25 PM ET
Size
10.2 KB
Accession
0001613103-25-000114
Insider Transaction Report
Form 4
Pieton Thierry
EVP & Chief Financial Officer
Transactions
- Award
Ordinary Shares
2025-07-28+8,699→ 39,958 total - Award
Performance Share Units
2025-07-28+21,747→ 21,747 total→ Performance Share Unit (21,747 underlying) - Award
Stock Option (Right to Buy)
2025-07-28+61,338→ 61,338 totalExercise: $91.97Exp: 2035-07-28→ Ordinary Shares (61,338 underlying)
Footnotes (6)
- [F1]Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
- [F2]Includes 505 shares acquired through dividend reinvestment since the last report filed by the reporting person.
- [F3]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- [F4]Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.
- [F5]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,747 shares will be issued. If maximum performance metrics are achieved, 43,494 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- [F6]These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Documents
Issuer
Medtronic plc
CIK 0001613103
Entity typeother
Related Parties
1- filerCIK 0002056622
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:25 PM ET
- Size
- 10.2 KB